BPC-157
Reported Onset
1–2 weeks
Primary Use
Accelerated tendon, ligament, and gut tissue repair.
Dose
250mcg - 500mcg
Frequency
1-2x daily
KPV
Reported Onset
2–4 weeks
Primary Use
Potent anti-inflammatory action, particularly for gut and skin inflammation.
Dose
100mcg - 500mcg
Frequency
1-2x daily
Community Verdict
Both anti-inflammatory gut/tissue peptides. KPV is oral-friendly vs BPC-157 injectable. The community generally selects between BPC-157 and KPV based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for BPC-157 or KPV at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified